Carnitine palmitoyltransferase II (CPT II) deficiency is the most common li
pid myopathy in adults and is characterized by exercise-induced pain, stiff
ness, and myoglobinuria. Retrospective analysis of patients with CPT II def
iciency has made it possible to correlate the presence of disease-causing m
utations in the CPT2 gene with residual CPT activity in muscle. We present
evidence that the ratio of CPT II activity to citrate synthase activity in
the skeletal muscle of patients presumed to have CPT II deficiency is impor
tant for predicting whether the patient has one, two, or no mutations in th
e CPT2 gene. This finding will assist in the future correlation of the phen
otype with the genotype and in identifying manifesting heterozygotes. (C) 1
999 John Wiley & Sons, Inc.